文献速递脑血管病

卒中发作后4.5-9小时静脉溶栓:TRISP协作组队列研究

Intravenous Thrombolysis 4.5-9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration.
PubMed 文献 · Ann Neurol · 2023-05-13

TRISP前瞻性多中心队列研究纳入15827例卒中患者,比较发病后4.5-9小时与0-4.5小时静脉溶栓的安全性及有效性。倾向评分加权分析显示两组症状性颅内出血、不良功能结局和死亡率无显著差异。在4.5-9小时组中,使用先进神经影像选择患者与死亡率降低50%相关。

要点

  • 4.5-9小时静脉溶栓与0-4.5小时相比,症状性颅内出血、不良功能结局和死亡率无显著差异。
  • 4.5-9小时组中使用先进神经影像与死亡率降低相关(9.9% vs 19.7%;ORadjusted 0.51)。
  • 4.5-9小时组中74.9%的患者卒中发作时间明确。

核心结论

  • 在选择的卒中患者中,发病后4.5-9小时静脉溶栓与4.5小时内溶栓相比,症状性颅内出血、不良结局和死亡率无显著差异。
  • 在4.5-9小时组中,使用先进神经影像选择患者与死亡率降低相关。

研究设计与样本

  • TRISP协作组的前瞻性多中心队列研究。
  • 共纳入15827例患者,其中663例(4.2%)在发病后4.5-9小时接受静脉溶栓,15164例(95.8%)在4.5小时内接受静脉溶栓。

主要发现

  • 倾向评分加权二元逻辑回归分析显示,4.5-9小时组与0-4.5小时组相比,症状性颅内出血的ORadjusted为0.80(95% CI 0.53-1.17),不良功能结局(改良Rankin量表3-6分)的ORadjusted为1.01(95% CI 0.83-1.22),死亡率的ORadjusted为0.80(95% CI 0.61-1.04),均无显著差异。
  • 在4.5-9小时组中,使用先进神经影像(CT灌注、MR灌注或MR弥散加权成像液体衰减反转恢复)与仅使用非先进神经影像相比,死亡率分别为9.9% vs 19.7%,ORadjusted为0.51(95% CI 0.33-0.79)。
  • 4.5-9小时组中74.9%的患者卒中发作时间明确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the safety and effectiveness of intravenous thrombolysis (IVT) >4.5-9 hours after stroke onset, and the relevance of advanced neuroimaging for patient selection. METHODS: Prospective multicenter cohort study from the ThRombolysis in Ischemic Stroke Patients (TRISP) collaboration. Outcomes were symptomatic intracranial hemorrhage, poor 3-month functional outcome (modified Rankin scale 3-6) and mortality. We compared: (i) IVT >4.5-9 hours versus 0-4.5 hours after stroke onset and (ii) within the >4.5-9 hours group baseline advanced neuroimaging (computed tomography perfusion, magnetic resonance perfusion or magnetic resonance diffusion-weighted imaging fluid-attenuated inversion recovery) versus non-advanced neuroimaging. RESULTS: Of 15,827 patients, 663 (4.2%) received IVT >4.5-9 hours and 15,164 (95.8%) within 4.5 hours after stroke onset. The main baseline characteristics were evenly distributed between both groups. Time of stroke onset was known in 74.9% of patients treated between >4.5 and 9 hours. Using propensity score weighted binary logistic regression analysis (onset-to-treatment time >4.5-9 hours vs onset-to-treatment time 0-4.5 hours), the probability of symptomatic intracranial hemorrhage (ORadjusted 0.80, 95% CI 0.53-1.17), poor functional outcome (ORadjusted 1.01, 95% CI 0.83-1.22), and mortality (ORadjusted 0.80, 95% CI 0.61-1.04) did not differ significantly between both groups. In patients treated between >4.5 and 9 hours, the use of advanced neuroimaging was associated with a 50% lower mortality compared with non-advanced imaging only (9.9% vs 19.7%; ORadjusted 0.51, 95% CI 0.33-0.79). INTERPRETATION: This study showed no evidence in difference of symptomatic intracranial hemorrhage, poor outcome, and mortality in selected stroke patients treated with IVT between >4.5 and 9 hours after stroke onset compared with those treated within 4.5 hours. Advanced neuroimaging for patient selection was associated with lower mortality. ANN NEUROL 2023;94:309-320.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Altersberger VL, Sibolt G, Enz LS, et al. Intravenous Thrombolysis 4.5-9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration. Ann Neurol. 2023. PMID: 37114466. doi:10.1002/ana.26669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。